Major postmarketing vigilance revisions are now in force. A revised medical device guidance document on postmarketing vigilance (MEDDEV 2.12-1 rev 5) came into force on January 1, 2008. Providing more guidance than the previous version, the new document includes new reporting terminology and concepts such as "periodic summary reporting" and "trend reporting."
Medical Device Postmarketing Vigilance Reporting: Update and Expectations for Manufacturers - Webinar By GlobalCompliancePanel
12 June 2012, Wilmington,DE, United States
Introduction
Venue
Online Training
Online Training, 1000 N West Street, Suite 1200, Wilmington,DE, 19801, United States
Useful links
Organised by
GlobalCompliancePanel
Contact information
Related events
New Zealand Institute of Chemistry Conference 2024 (NZIC-24)
24 November 2024 14:00 - 28 November 2024 14:00, Dunedin, New Zealand
TAC 2025 - 60th Anniversary Conference
14 April 2025 09:00 - 16 April 2025 17:00, Guildford, United Kingdom
What's in that Perfume? - The Chemistry behind an iconic Christmas gift
3 December 2024 18:00-20:00, London, United Kingdom
Chemistry Teaching in Practice
9 January 2025 09:30-16:00, Oxford, United Kingdom
Search
Advertisement
Spotlight
Explore
Membership
